To increase access to Hepatitis C (HCV) medications, the Governor is also proposing to increase funding for HCV prevention, testing and treatment programs, such as education, patient navigation, and HCV prevention programs in primary care and other settings.  HCV-related deaths have exceeded HIV-related deaths in the state outside of New York City since 2007, and with injecting drug use as the most common risk factor, the opioid epidemic has fueled a rise in new HCV cases. One in five persons with HIV is co-infected with HCV, and studies show that over 90 percent of people who are treated can be cured of HCV. New direct-acting antiviral drugs have minimal side effects and can prevent the need for a liver transplant, cirrhosis, liver failure, liver cancer or death.


Read more here!